Korea Otsuka Pharmaceutical Co., Ltd.
Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
- Conditions
- SchizophreniaBipolar 1 Disorder
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1030
- Registration Number
- NCT03386851
- Locations
- 🇰🇷
St.John of God Hospital, Gwangju, Korea, Republic of
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
- Conditions
- Long-Acting InjectionLAIAripiprazoleSchizophreniaAntipsychotics
- Interventions
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 201
- Registration Number
- NCT03376763
- Locations
- 🇰🇷
Cha Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Eulji University Hospital, Daejeon, Korea, Republic of
🇰🇷Kangbuk Samsung Hospital, Seoul, Korea, Republic of
Samsca Post Marketing Surveillance Study
- Conditions
- Hypervolemic and Euvolemic Hyponatremia
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 908
- Registration Number
- NCT02722863
- Locations
- 🇰🇷
Daegu Catholic University Medical Center, Daegu, Korea, Republic of
🇰🇷Chungnam National University Hospital, Daejeon, Korea, Republic of
🇰🇷Bong Seng Hospital, Busan, Korea, Republic of
Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT02352285
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seoul, Korea, Republic of
Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT02250170
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seoul, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 65
- Registration Number
- NCT02094469
- Locations
- 🇰🇷
Yangsan Busan University Hospital, Busan, Korea, Republic of
A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT02087007
- Locations
- 🇰🇷
Yangsan Busan University Hospital, Busan, Korea, Republic of
A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 33
- Registration Number
- NCT01942083
OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.
- Conditions
- Healthy
- First Posted Date
- 2013-08-19
- Last Posted Date
- 2014-11-07
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT01925521
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
ABF Tourette's Disorder Post Marketing Surveillance Study
- Conditions
- Tourette's Disorder
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 692
- Registration Number
- NCT01795105
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
🇰🇷Chonbuk National University Hospital, Jeonju, Korea, Republic of